Project Grant HT9425261E019
Award Date 5/1/26
Completion Date 4/30/29
Dollars Obligated $998K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
- Federal Grant Award Summary The Methodist Hospital Research Institute received a $662,742 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective October 1, 2025, through September 30, 2028. This award supports a hybrid implementation-efficacy trial investigating home neuromodulation as a therapeutic intervention for neurogenic bladder management in individuals with spinal cord injury. The research will be...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Methodist Hospital Research Institute a $323,000 project grant effective September 1, 2025, through August 31, 2029, under the Military Medical Research and Development program (CFDA 12.420). The award supports research aimed at targeting METTL3 to overcome drug resistance in metastatic clear cell renal cell carcinoma. This project will deliver hypothesis-driven biomedical research and development activities...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $939,325 to the Weizmann Institute of Science on November 1, 2025, under the Military Medical Research and Development program (CFDA 12.420) to support the GLOBALS (Global Omic Biomarker Research for ALS) initiative. This three-year project, extending through October 31, 2028, funds advanced biomedical research focused on discovering and developing omic biomarkers for amyotrophic lateral sclerosis (ALS). The research...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Denver Research Institute a $2.31M Project Grant under the Military Medical Research and Development program (CFDA 12.420) beginning July 1, 2025, and concluding June 30, 2029. The award funds the Development and Evaluation of a Care Pathway for Evaluation and Management of the Respiratory Syndromes of Amyotrophic Lateral Sclerosis (CAPRESA), a clinical research initiative to be conducted at the Institute's Denver, Colorado...
- Federal Project Grant Award Summary Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) received a $997,807 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 through June 30, 2028. The award supports the development of ultrasensitive immunoassays for detecting TDP-43 pathology, a biomarker associated with neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). This...
- Federal Grant Award Summary New York University School of Medicine received a $1.0 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the three-year period from June 1, 2026, through May 31, 2029. The award funds research into diffusion magnetic resonance imaging (MRI) biomarkers of axonal degeneration in amyotrophic lateral sclerosis (ALS). This research initiative will advance understanding of neurodegeneration...
- The Defense Health Agency (DHA) awarded a $646,000 Project Grant to The Methodist Hospital Research Institute on August 1, 2025, under the Military Medical Research and Development program (CFDA 12.420). The research initiative, "Reprogramming Protumoral Neutrophils to Enhance ICI-Based Responses in Bladder Cancer," will be conducted in Houston, Texas, with completion scheduled for July 31, 2027. This award supports translational research aimed at developing innovative...
- Federal Project Grant Award Summary Award Details: Modulo Bio, Inc. received a $1.74M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) with an award date of May 1, 2026, and a performance period through April 30, 2028. This administrative modification corrected the payment office DODAAC code for processing purposes without altering the award amount or other terms and conditions. Products and Services: Under this award,...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Beckman Research Institute of the City of Hope a $177,992 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2027. The award supports the generation of novel tools and development of targeted approaches for AL (light-chain) amyloidosis, a serious protein misfolding disorder. Research activities will be conducted at the Institute's...
- This $444,125 federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports research by The Methodist Hospital Research Institute in Houston, TX to identify LIAX binding partners for preventing resistance. The grant aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical research. The project will run from April 1, 2025 to March 31, 2027 and focus on...